Delivery Order SPE2DR25D2104-SPE2DR26F3RFE
Award Date 12/11/25
Potential Completion Date 12/12/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen (semaglutide injection), a diabetes and weight management medication. The contract, valued at $29,770.98, is a firm fixed-price delivery order with a completion date of October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to...
- The Defense Logistics Agency awarded a $1,525.16 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by July 16, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under the company's larger pharmaceutical supply relationship with the Defense Logistics...
- The Defense Logistics Agency awarded a $13,137.57 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price contract is set to conclude on October 27, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. As a non-set-aside procurement, the award reflects AmerisourceBergen's continued role as a critical pharmaceutical supplier within the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,845.70 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pen injections, with completion scheduled for December 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order valued at $10,380.95 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract involves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,060.06 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 ml pen injections. This firm fixed-price delivery order, awarded on October 31, 2025, with completion targeted for November 3, 2025, represents a purchase of pharmaceutical products to support federal medical supply needs. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,926.22 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used for weight management and diabetes treatment. The contract was competitively awarded without a set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of November 25, 2025. Performance will be completed from the vendor's location in...
- The Defense Logistics Agency awarded a delivery order valued at $17,657.50 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 6, 2025, awarded on November 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance for this...
- The Defense Logistics Agency awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens on September 27, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order represents a direct purchase of the FDA-approved diabetes and weight management medication through a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to the place of...